Chizuko Hashimoto
Yamato Municipal Hospital(JP)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CNS Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders, Chronic Lymphocytic Leukemia Research, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study(2011)598 cited
- → Prognostic impact of extranodal involvement in diffuse large B‐cell lymphoma in the rituximab era(2011)102 cited
- → Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type(2012)97 cited
- → Central nervous system event in patients with diffuse large B‐cell lymphoma in the rituximab era(2011)88 cited
- → Central nervous system involvement in diffuse large B‐cell lymphoma(2010)85 cited
- → Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B‐cell lymphoma in the rituximab era(2013)57 cited
- → The therapeutic effect of rituximab on CD5‐positive and CD5‐negative diffuse large B‐cell lymphoma(2009)42 cited
- → European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients(2013)39 cited
- → Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy(2015)34 cited
- → Serum ferritin level is a prognostic marker in patients with peripheral T‐cell lymphoma(2016)34 cited